Results 41 to 50 of about 98,010,213 (261)

Hyperimmunized Chickens Produce Neutralizing Antibodies against SARS-CoV-2 [PDF]

, 2022
The novel severe acute respiratory syndrome (SARS) coronavirus, SARS-CoV-2, is responsible for the global COVID-19 pandemic. Effective interventions are urgently needed to mitigate the effects of COVID-19 and likely require multiple strategies.
Rodrigo A. Gallardo, Sofia Egaña-Labrin, Michael G. Wallach, Gallardo, Rodrigo A, Egaña-Labrin, Sofia, Aarthi Narayanan, Aston, Emily J., Aston, Emily J, Gallardo, Rodrigo A., Wallach, Michael G., Narayanan, Aarthi, Wallach, Michael G, Emily J. Aston, Egaña-Labrin, S, Gallardo, RA, Wallach, MG, Narayanan, A, Aston, EJ   +17 more
core   +1 more source

Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH-and Cysteine Protease-Independent Fc gamma R Pathway [PDF]

, 2011
Copyright © 2011, American Society for Microbiology. All Rights Reserved.Public health measures successfully contained outbreaks of the severe acute respiratory syndrome coronavirus (SARS-CoV) infection.
Cheung, Chung y, Marc Daëron, Li, PH, Altmeyer, Ralf, Ping H. Li, Leung, Hiu L, Escriou, N, Dutry, Isabelle, Ming S. Yip, Kien, Francois, Cheung, CY, Dutry, I, Li, Ping H, Benoît Callendret, Nal, B, Chung Y. Cheung, Altmeyer, R, Peiris, J S Malik, Ralf Altmeyer, Bruzzone, R, Jaume, Martial, Martial Jaume, Nicolas Escriou, Callendret, B, Isabelle Dutry, Escriou, Nicolas, Beatrice Nal, Kien, F, Francois Kien, Jaume, M, Yip, MS, Bruzzone, Roberto, J. S. Malik Peiris, Yip, Ming S, Daëron, Marc, Roberto Bruzzone, Hiu L. Leung, Leung, HL, Peiris, JSM, Nal, Beatrice, Daeron, M   +40 more
core   +1 more source

SARS-CoV-2 lung viral loads.

, 2023
Despite development of effective SARS-CoV-2 vaccines, a sub-group of vaccine non-responders depends on therapeutic antibodies or small-molecule drugs in cases of severe disease.
Harsh Bansia (9381458), Klaus Koefoed (469369), Anne Worsaae (2535511), Laurent-Michel Vuillard (12525714), Mariane Høgsbjerg Schleimann (9460369), Mike Vestergaard (17014775), Anna Halling Folkmar Rahimic (17014787), Torben Gjetting (534390), Stine Sofie Frank Lende (12997305), Anna Karina Juhl (17014790), Maria Lange Pedersen (17014784), Randi Westh Hansen (17014772), Frederik Holm Rothemejer (17014778), Deijona Brown (17014781), Lars Østergaard (148140), Amédée Des Georges (17014793), Martin Tolstrup (148124), Nanna Møller Barnkob (17014769)   +17 more
core   +1 more source

Seroprevalence of anti-SARS-CoV-2 antibodies in participants with at-risk occupations.

, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies in participants with at-risk occupations.
Witthawat Wiriyarat (119671), Kuntida Kitidee (3935783), Poj Intalapaporn (12468922), Noparat Mongkalangoon (12468943), Hatairat Lerdsamran (324344), Nirada Siriyakorn (2142928), Somrak Sirikhetkon (12468925), Suteema Sawadpongpan (12468931), Sopon Iamsirithaworn (260152), Jarunee Prasertsopon (2602375), Ranida Techasuwanna (12468940), Nattakan Thinpan (12468934), Anek Mungaomklang (357147), Suthee Saritsiri (12468916), Worawat Dangsakul (12468928), Pilailuk Okada (12468937), Kriengkrai Prasert (10947556), Pilaipan Puthavathana (119686), Ratikorn Anusorntanawat (12468919), Kantima Sangsiriwut (324342)   +19 more
core   +1 more source

Seroprevalence of anti-sars-cov-2 antibodies among blood donors participants’ flow chart.

, 2023
Seroprevalence of anti-sars-cov-2 antibodies among blood donors participants’ flow chart.
Youssouf Diam Sidibe (14333906), Fara Wagbo Temessadouno (11113999), Jean Gilbert Ndong (14333903), Tidiani Fane (14333915), Marie Hortense Nkokolo massamba (14333921), Francisco Luquero (4369771), Sonia Guiramand (14093954), Clair Mills (75046), Yves Coppieters (3524246), Alhassane Ba (6175445), Aminata Daou (14333909), Komla Mawunya Vuti (14333918), Idrissa Compaore (14333912), Etienne Gignoux (3072651), Erica Simons (12289456), Nada Malou (333344)   +15 more
core   +1 more source

SARS-CoV-2-Neutralizing Antibodies

Vaccines
The COVID-19 pandemic, triggered by the SARS-CoV-2 virus, has profoundly and permanently affected many aspects of the world [...]
Yawen Liu, Jianhui Nie
openaire   +6 more sources

Equine Hyperimmune Serum against the Inactivated SARS-CoV-2 Has Antibodies Neutralizing Titers [PDF]

Brazilian Archives of Biology and Technology
The use of passive immunization could be a strategy for the control of SARS-CoV-2 infections. Our study proposes to produce anti-SARS-CoV-2 antibodies from the immunization of horses, and purify F(ab’)2 fragment aiming to provide a therapy capable of ...
Neida Lucia Conrad, Vitória Sequeira Gonçalves Zorzi, Francisco Denis Souza Santos, César Graner, Marcelle Moura Silveira, Juliana Schons Gularte, Micheli Filippi, Karoline Schallenberger, Juliane Deise Fleck, Bruno Lopes Abbadi, Cristiano Valim Bizarro, Pablo Machado, Luiz Augusto Basso, Fabrício Rochedo Conceição, Carlos Eduardo Wayne Nogueira, Fernando Rosado Spilki, Fábio Pereira Leivas Leite   +16 more
doaj   +1 more source

Performance of LFA and ECLIA in detecting anti-SARS-CoV-2 antibodies.

, 2021
Anti-SARS-CoV-2 IgM (A) and IgG (B) antibodies were detected using a lateral flow immunochromatographic assay (LFA), and anti-SARS-CoV-2 total antibodies were detected using an electrochemiluminescence immunoassay (ECLIA).
Hiroo Hasegawa (3586247), Kouichi Morita (201947), Shigeru Kohno (278864), Yui Shigeishi (11495246), Kenji Ota (7320323), Kosuke Kosai (535643), Jiro Yasuda (32563), Hironori Sakai (449393), Koichi Izumikawa (535642), Fumitaka Nishimura (11495243), Koya Ariyoshi (7877), Norihito Kaku (7439288), Rina Tachiki (11495249), Kei Sakamoto (402255), Hiroshi Mukae (409973), Katsunori Yanagihara (535647), Daisuke Sasaki (82102)   +16 more
core   +1 more source

SARS-CoV-2 and Anti-Cardiolipin Antibodies

Clinical Medicine Insights: Case Reports, 2020
The current COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to distinct diagnostic and management challenges for front-line healthcare workers. The risk of excessive coagulation activation leading to a cascade of thrombotic events in critically ill patients with SARS-CoV-2 is now well reported.
Mazen Jizzini, Mohsin Shah, Kehua Zhou
openaire   +4 more sources

Saliva SARS-CoV-2 Antibody Prevalence in Children

Microbiology Spectrum, 2021
Comprehending humoral immunity to SARS-CoV-2, including in children, is crucial for future public health and vaccine strategies. Others have suggested that mucosal antibody measurement could be an important and more convenient tool to evaluate humoral immunity compared to circulating antibodies.
Maya W. Keuning, Marloes Grobben, Anne-Elise C. de Groen, Eveline P. Berman-de Jong, Merijn W. Bijlsma, Sophie Cohen, Mariet Felderhof, Femke de Groof, Daniel Molanus, Nadia Oeij, Maarten Rijpert, Hetty W. M. van Eijk, Gerrit Koen, Karlijn van der Straten, Melissa Oomen, Remco Visser, Federica Linty, Maurice Steenhuis, Gestur Vidarsson, Theo Rispens, Frans B. Plötz, Marit J. van Gils, Dasja Pajkrt   +22 more
openaire   +3 more sources